United Therapeutics Corporation (UTHR)

Exchange
NASDAQ
Symbol
UTHR
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
Country
USA

Stock price

At close: November 5, 2024

  • Open
    373.03
  • High
    382.95
  • Low
    373.03
  • Close
    382.77
  • Volume
    277,835

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
6.56
Receivables turnover
8.13
Payables turnover
130.91
Working capital turnover
0.83
Days of inventory on hand (DOH)
55.66
Days of sales outstanding (DSO)
44.88
Number of days of payables
2.79
Fixed asset turnover
2.17
Total asset turnover
0.32
 Liquidity ratios
Current ratio
4.41
Quick ratio
4.09
Cash ratio
3.74
Cash conversion cycle
97.76
 Solvency ratios
Debt-to-assets ratio
0.04
Debt-to-capital ratio
0.05
Debt-to-equity ratio
0.05
Financial leverage ratio
1.20
Interest coverage
22.49
 Profitability ratios
Gross profit margin
91.26%
Operating profit margin
52.24%
Pretax margin
56.18%
Net profit margin
43.42%
Operating return on assets (Operating ROA)
16.53%
Return on assets (ROA)
13.74%
Return on total capital
21.22%
Return on equity (ROE)
16.46%